Identification of interdependent variables that influence coreceptor switch in R5 SHIVSF162P3N-infected macaques

被引:0
|
作者
Ke Zhuang
Andres Finzi
Jonathan Toma
Arne Frantzell
Wei Huang
Joseph Sodroski
Cecilia Cheng-Mayer
机构
[1] Aaron Diamond AIDS Research Center,Centre de Recherche du CHUM
[2] Université de Montréal,Dana Faber Cancer Institute
[3] Monogram Biosciences,undefined
[4] Inc,undefined
[5] Harvard Medical School,undefined
来源
关键词
R5 SHIV; Coreceptor switch; CD4 binding; Macrophage infection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 36 条
  • [31] Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism
    Scinto, Hanna B.
    Gupta, Sandeep
    Thorat, Swati
    Mukhtar, Muhammad M.
    Griffiths, Anthony
    Delgado, Jennifer
    Plake, Elizabeth
    Vyas, Hemant K.
    Strickland, Amanda
    Byrareddy, Siddappa N.
    Montefiori, David C.
    LaBranche, Celia
    Pal, Ranajit
    Treece, Jim
    Orndorff, Sharon
    Ferrari, Maria Grazia
    Weiss, Deborah
    Chenine, Agnes-Laurence
    McLinden, Robert
    Michael, Nelson
    Kim, Jerome H.
    Robb, Merlin L.
    Rerks-Ngarm, Supachai
    Pitisuttithum, Punnee
    Nitayaphan, Sorachai
    Ruprecht, Ruth M.
    JOURNAL OF VIROLOGY, 2018, 92 (14)
  • [32] HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3
    Cristillo, Anthony D.
    Lisziewicz, Julianna
    He, Leilei
    Lori, Franco
    Galmin, Lindsey
    Trocio, Jeffrey N.
    Unangst, Tami
    Whitman, Lucia
    Hudacik, Lauren
    Bakare, Nyasha
    Whitney, Stephen
    Restrepo, Susana
    Suschak, John
    Ferrari, Maria Grazi
    Chung, H. K.
    Kalyanaraman, Vaniambadi S.
    Markham, Phillip
    Pal, Ranajit
    VIROLOGY, 2007, 366 (01) : 197 - 211
  • [33] Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3
    Kent, SJ
    Dale, CJ
    Ranasinghe, C
    Stratov, I
    De Rose, R
    Chea, S
    Montefiori, DC
    Thomson, S
    Ramshaw, IA
    Coupar, BEH
    Boyle, DB
    Law, M
    Wilson, KM
    Ramsay, AJ
    VACCINE, 2005, 23 (42) : 5009 - 5021
  • [34] Comparison of viral burden and disease progression in Chinese-origin rhesus macaques infected with common experimentally applied chimeric virus: SHIV-1157ipd3N4, SHIV-162P3, or SHIV-KB9
    Wang, Wei
    Cong, Zhe
    Jiang, Hong
    Chen, Ting
    Jin, Guang
    Xiong, Jing
    Qin, Chuan
    Wei, Qiang
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (04) : 247 - 257
  • [35] Emergence of gp120 V3 Variants Confers Neutralization Resistance in an R5 Simian-Human Immunodeficiency Virus-Infected Macaque Elite Neutralizer That Targets the N332 Glycan of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein
    Sadjadpour, Reza
    Donau, Olivia K.
    Shingai, Masashi
    Buckler-White, Alicia
    Kao, Sandra
    Strebel, Klaus
    Nishimura, Yoshiaki
    Martin, Malcolm A.
    JOURNAL OF VIROLOGY, 2013, 87 (15) : 8798 - 8804
  • [36] Reaction dynamics of the Ca(D-1(2), P-3(J))+RI->CaI*+R (R=CH3, C2H5 and n-C3H7) system: Chemiluminescence, photon yield, electronic branching ratio and influence of the radical group
    Garay, M
    Orea, JM
    Urena, AG
    CHEMICAL PHYSICS, 1996, 207 (2-3) : 451 - 459